Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

Crossref

1. The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study

- Heidar Sharafi

- Seyed Moayed Alavian

- Bita Behnava

- Ali Pouryasin

- Maryam Keshvari

2. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4

- AM Attallah

- D Omran

- M S Marie

- Mohamed Abdelrazek

- A Salama

- R El Essawey

- L Mobarak

- S Maklad

- A Omar

3. Recipient interleukin 6 gene polymorphism and expression predict HCV recurrence post liver transplantation

- Reham M. Dawood

- Ghada M. Salum

- Mai Abd El-Meguid

- Mohamed Shemis

- Ashraf O. Abdel Aziz

- Mostafa K. El Awady

4. Data Mining and Machine Learning Algorithms Using <i>IL28B</i> Genotype and Biochemical Markers Best Predicted Advanced Liver Fibrosis in Chronic Hepatitis C

- Hend Ibrahim Shousha

- Abubakr Hussein Awad

- Dalia Abdelhamid Omran

- Mayada Mohamed Elnegouly

- Mahasen Mabrouk

5. Mysterious Linkages Between Hepatitis C Virus Genotypes, Interleukin-28B Genotypes and Viral Clearance- A Meta-Analysis

- Seyed Hossein Aalaei-Andabili

- Bita Behnava

- Shima Salimi

- Heidar Sharafi

- Seyed Moayed Alavian

6. Impact of IL-28B gene polymorphism on chronic hepatitis-C patients progression with diabetes and non-diabetes

- Rehab M. Ateya

- Samir A. Afifi

- Nagla Abd Al Monem

- Amira S. Al-Karamany

- Ahmed A. Bessar

- Fatma Rageh

- Samar S. Ahmed

- Dalia Ghareeb

7. Predictive Value of IL-28B rs12979860 Variants for Peg-IFN, Sofosbuvir Plus Ribavirin Treatment of HCV Infection in Pakistani Population

- Qaisar Ali

- Irfan Kalam

- Sajjad Ullah

- Arshad Jamal

- Muhammad Imran

- Shafi Ullah

- Khurshid Iqbal

- Ahmed B Waqar

9. Predictive power of Interleukin–28B gene variants for outcome of Hepatitis C Virus genotype 4 in Egyptians: A systematic review and meta-analysis

- Mohamed Abd El-Fattah

10. Development of a gene signature for predicting cirrhosis risk score of chronic liver disease associated with HCV infection in Egyptians

- Reham M. Dawood

- Ghada M. Salum

- Mai Abd El-Meguid

- Ahmed Elsayed

- Ayman Yosry

- Ashraf Abdelaziz

- Hend Ibrahim Shousha

- Mohamed Mahmoud Nabeel

- Mostafa K. El Awady

11. The Impact of Interleukin 28b Gene Polymorphism on the Virological Response to Combined Pegylated Interferon and Ribavirin Therapy in Chronic HCV Genotype 4 Infected Egyptian Patients Using Data Mining Analysis

- Marwa Khairy

- Rabab Fouad

- Mahassen Mabrouk

- Wafaa El-Akel

- Abu Bakr Awad

- Rabab Salama

- Mayada Elnegouly

- Olfat Shaker

12. The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients

- Moutaz Derbala

- Nasser M. Rizk

- Saad Al-Kaabi

- Anil John

- Manik Sharma

- Nazeeh El-dweik

- Rafie Yakoob

- Fuad Pasic

- Muneera Almohanadi

- Khalid Alejji

- Abdulatif Abdelmola

- Mohamed Butt

13. ASSESSING PREDICTORS OF DIRECTLY ACTING ANTIVIRALS’ FAILURE AS A FURTHER STEP TOWARDS MORE EFFICIENT HCV ELIMINATION PROGRAMS: IL28B (IFNL4) GENE POLYMORPHISM HAS NO ROLE WHILE HIGHER ESTIMATED CREATININE CLEARANCE IS A FORGOTTEN FACTOR

- Ahmed KAMAL

- Cecil MATTA

- Heba Akram MOHSIN

- Abeer Shawki ELHADIDI

- Ramy Mohamed GHAZY

- Heba Hany OMAR

- Mona TAHOUN

- Nema Abdelhameed MOHAMED

14.

15. Role of IL-28B polymorphisms in virologic response to combined pegylated interferon and ribavirin therapy in genotype 4 chronic HCV infected patients with and without cirrhosis

- Amira Youssef Shaala

- Mona Gamal Morsi

- Reem Abdel Hameed Harfoush

- Ehab Hassan ElKhouly

- Mohamed Abdel Rahman Ahmed

- Mohamed Nabil Roshdy

16. Hepatitis C genotype 4: The past, present, and future

- Tawhida Y Abdel-Ghaffar

17. Genetic polymorphisms of ICAM 1 and IL28 as predictors of liver fibrosis severity and viral clearance in hepatitis C genotype 4

- Nasser M. Rizk

- Moutaz F. Derbala

18. Tumor necrosis factor-α -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients

- Noha G Bader El Din

- Sally Farouk

- Reem El-Shenawy

- Marwa K Ibrahim

- Reham M Dawood

- Mostafa M Elhady

- Ahmed M Salem

- Naglaa Zayed

- Ahmed Khairy

- Mostafa K El Awady

19. Association between IFN-λ 3 Gene Polymorphisms and Outcome of Treatment with Direct Acting Antivirals in Chronic HCV-Infected Egyptian Patients

- Islam El-Garawani

- Sobhy Hassab El-Nabi

- Marwa Gadallah

- Eman Abdelsameea

20. The impact of genetic variations in sofosbuvir metabolizing enzymes and innate immunity mediators on treatment outcome in HCV-infected patients

- Marwa K. Ibrahim

- Mohamed AbdElrahman

- Noha G. Bader El Din

- Salwa Tawfik

- Sherief Abd-Elsalam

- Dalia Omran

- Amal Z. Barakat

- Sally Farouk

- Hassan Elbatae

- Mostafa K. El Awady

21. Value of IFNL3 genetic polymorphism in the prediction of HCV treatment response to direct-acting antiviral drugs versus interferon therapy

- Samar E. Ghanem

- Maha Elsabaawy

- Nashwa shebl

- Eman Abdelsameea

- Warda Othman

- Fathia I. EL‑Bassal

- Gamalat A. Elgedawy

- Dalia M. Elsabaawy

- Marwa L. Helal

22. A simple real-time polymerase chain reaction assay using SYBR Green for hepatitis C virus genotyping

- Hosam Zaghloul

- A. A. El Morsi

- H. E. Soweha

- Ashraf Elsayed

- S. Seif

- Hossam El-Sharawy

23. IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients

- Fatma Omar Khalil

- Ayman Alsebaey

- Zeinab Abdelaziz Kasemy

- Sabry Moawad Abdelmageed

- Hanan Mosaad Bedair

- Shimaa Abdelsattar

24. Exploring the Impact of Different Inflammatory Cytokines on Hepatitis C Virus Infection

- Noha G. Bader El Din

- Sally Farouk